| 產(chǎn)品名稱 |
Proteus mirabilis Hauser |
| 商品貨號 |
B223010 |
| Strain Designations |
P11/7551N |
| Isolation |
clinical isolate, Maryland |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Preceptrol® |
no |
| Type Strain |
no |
| Comments |
Bacteriocin typing methods |
| Medium |
ATCC® Medium 3: Nutrient agar or nutrient broth
|
| Growth Conditions |
Temperature: 37.0°C |
| Name of Depositor |
BA Grajewski |
| Chain of Custody |
ATCC <<--BA Grajewski<<--J.W. Kusek <<--- NIH Clinical Pathology Lab |
| References |
Kusek JW, Herman LG. Typing of Proteus mirabilis by bacteriocin production and sensitivity as a possible epidemiological marker. J. Clin. Microbiol. 12: 112-120, 1980. PubMed: 6999013
|
